Published September 14, 2026
The U.S. Judicial Panel on Multidistrict Litigation is set to hear oral arguments on September 24, 2026 in Chicago over whether to centralize federal lawsuits against Nevro Corporation into a new multidistrict litigation, according to legal trade publication Mealey's. Plaintiffs filed the motion on June 26, 2026, proposing the cases — 17 lawsuits filed across six jurisdictions as of early July, nine of which also name the FDA as a defendant — be consolidated as MDL No. 3195 in the Central District of California before Judge Josephine L. Staton, who already oversees the separate Boston Scientific spinal cord stimulator MDL.
The lawsuits allege Nevro's spinal cord stimulators were defectively designed, caused electric shocks and burning sensations, migrated or protruded through patients' skin, or failed outright, according to AboutLawsuits.com's coverage of the original motion. Some plaintiffs also allege sales representatives performed unlicensed medical procedures and that the FDA failed to adequately enforce device safety laws.
Nevro filed its opposition to the motion on August 6, 2026, arguing that centralization would slow the litigation down rather than streamline it. According to AboutLawsuits.com, the company contends plaintiffs haven't identified a common defective component and that patients' injuries vary too much from case to case to justify coordinated pretrial proceedings — echoing arguments manufacturers have made in similar MDL fights over spinal cord stimulators made by Abbott, whose own consolidation request is being argued at the same September 24 hearing.
Nevro joins Boston Scientific and Medtronic as device makers already facing centralized federal litigation over spinal cord stimulators, alongside a separate wave of cases against Abbott. Whether the panel grants or denies the Nevro request will determine whether the growing number of claims against the company proceed in a single coordinated court or continue to be filed individually across the country.
Whether or not the panel creates a new MDL, the underlying claims against Nevro aren't affected — the ruling only decides which court handles pretrial proceedings. If you were implanted with a Nevro spinal cord stimulator and experienced device failure, shocks, migration, or a revision surgery, see Atumio's Nevro case page for a free eligibility review, or start your case review directly.